Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-01

Clinical Trial Update: Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder? [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating inositol hexaphosphate as a potential treatment for bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inositol Hexaphosphate (inositol hexaphosphate)

Snippet

Sponsor: San Diego Veterans Healthcare System | Conditions: Bipolar Disorder, Manic Depression | Phase 1 | Status: COMPLETED